UPCC 09625 Immunosuppression-related Skin Cancer Prediction after Organ Transplantation (I-SPOT) (I-SPOT)

Enrolling By Invitation
18 years - 99 years
All
Phase N/A
385 participants needed
1 Location

Brief description of study

To externally validate and refine prediction models for a) incident and b) subsequent KC in a prospective multi-center cohort of kidney and liver transplant recipients, with detailed data on UV exposure, skin type, and photosensitivity.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 18 years - 99 years
  • Gender: All

TBD

Updated on 22 Apr 2026. Study ID: 25-1434
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator